Michael Lefenfeld's most recent trade in Immunome Inc was a trade of 6,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Michael Lefenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Michael Lefenfeld | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 15 Jan 2023 | 13,875 | 40,747 | - | 4 | 55,500 | Common Stock |
| Immunome Inc | Michael Lefenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Michael Lefenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Michael Lefenfeld | Director | Purchase of securities on an exchange or from another person at price $ 18.44 per share. | 24 May 2021 | 2,715 | 25,537 | - | 18.4 | 50,065 | Common Stock |
| Immunome Inc | Michael Lefenfeld | Director | Purchase of securities on an exchange or from another person at price $ 19.03 per share. | 24 May 2021 | 1,335 | 26,872 | - | 19.0 | 25,405 | Common Stock |
| Immunome Inc | Michael Lefenfeld | Director | Purchase of securities on an exchange or from another person at price $ 17.80 per share. | 24 May 2021 | 600 | 22,822 | - | 17.8 | 10,680 | Common Stock |
| Immunome Inc | Michael Lefenfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2020 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Michael Lefenfeld | Director | 06 Oct 2020 | 22,222 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Immunome Inc | Michael Lefenfeld | Director | 06 Oct 2020 | 22,222 | 22,222 | - | - | Common Stock | ||
| Immunome Inc | Michael Lefenfeld | Director | 06 Oct 2020 | 11,111 | 11,111 | - | - | Warrant (right to buy) | ||
| Immunome Inc | Michael Lefenfeld | Director | 06 Oct 2020 | 11,111 | 0 | - | - | Warrant (right to buy) |